Patents by Inventor David Kainer

David Kainer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR CONTROLLING CELL WALL BIOSYNTHESIS AND GENETICALLY MODIFIED PLANTS
    Publication number: 20240076686
    Abstract: The present disclosure provides methods of producing plants with preferred levels of cell wall biosynthesis; and uses of such plants. The inventors have identified that the GFR9, CCoAOMT and MYB41 genes are major regulators of the cell wall biosynthesis pathway. Plants with modulated cell wall biosynthesis, based on modulation of the expression or activity of the GFR9, CCoAOMT and MYB41 genes, have divergent uses including pulp and paper production, and bioproduct production.
    Type: Application
    Filed: June 15, 2023
    Publication date: March 7, 2024
    Inventors: Timothy J. Tschaplinski, Daniel A. Jacobson, David Kainer, Deborah A. Weighill, Anna K. Furches
  • Methods for controlling cell wall biosynthesis and genetically modified plants
    Patent number: 11725215
    Abstract: The present disclosure provides methods of producing plants with preferred levels of cell wall biosynthesis; and uses of such plants. The inventors have identified that the GFR9, CCoAOMT and MYB41 genes are major regulators of the cell wall biosynthesis pathway. Plants with modulated cell wall biosynthesis, based on modulation of the expression or activity of the GFR9, CCoAOMT and MYB41 genes, have divergent uses including pulp and paper production, and bioproduct production.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: August 15, 2023
    Assignees: UT-Battelle, LLC, University of Tennessee Research Foundation
    Inventors: Timothy J. Tschaplinski, Daniel A. Jacobson, David Kainer, Deborah A. Weighill, Anna K. Furches
  • SPECIFIC STRUCTURAL VARIANTS DISCOVERED WITH NON-MENDELIAN INHERITANCE
    Publication number: 20220101945
    Abstract: The present disclosure is directed to methods of identifying structural variants (SVs) from single nucleotide polymorphisms (SNPs) that demonstrate non-Mendelian inheritance pattern (NMI) and finding the biological relevance of the SVs through machine learning. Also disclosed are processors programmed to identify biologically-relevant SVs and computer-readable storage devices comprising instructions to identify biologically-relevant SVs.
    Type: Application
    Filed: September 28, 2021
    Publication date: March 31, 2022
    Inventors: Michael R. Garvin, Daniel A. Jacobson, David Kainer, Erica Teixeira Prates
  • METHODS FOR CONTROLLING CELL WALL BIOSYNTHESIS AND GENETICALLY MODIFIED PLANTS
    Publication number: 20200102571
    Abstract: The present disclosure provides methods of producing plants with preferred levels of cell wall biosynthesis; and uses of such plants. The inventors have identified that the GFR9, CCoAOMT and MYB41 genes are major regulators of the cell wall biosynthesis pathway. Plants with modulated cell wall biosynthesis, based on modulation of the expression or activity of the GFR9, CCoAOMT and MYB41 genes, have divergent uses including pulp and paper production, and bioproduct production.
    Type: Application
    Filed: October 2, 2019
    Publication date: April 2, 2020
    Inventors: Timothy J. Tschaplinski, Daniel A. Jacobson, David Kainer, Deborah A. Weighill, Anna K. Furches